100 EUR discount on all conferences, arranged by EBD Group.

Swedish medtech company Getinge raised its adjusted EBITA margin to 15.1% in the third quarter of 2026, from 13.1% a year earlier, while organic sales grew 2.1%. The company kept its forecast of 3–5% organic sales growth for the full year.

Finnish pharmaceutical company Orion has upgraded its full-year 2026 outlook for both net sales and operating profit, as royalty income has grown faster than expected so far this year.

Swedish investment firm EQT has agreed to acquire diagnostics and life science tools company Qiagen through an all-cash public takeover offer, valuing the company at an enterprise value of about EUR 10.8 billion (USD 12.1 billion), including net debt.

Thomas Eldered, co-founder of Recipharm and founder of the investment company Flerie, has been appointed senior advisor to Sciety. He brings more than 35 years of experience from the pharmaceutical industry as an entrepreneur, executive, and investor.